Participants who had previously lost weight with semaglutide were randomized to either continue on the medication or switch to a placebo
Among GLP-1 receptor agonists that are currently available, semaglutide 1.0 mg has previously shown the greatest effect for weight loss
burping or belching dyspepsia (indigestion): This side effect can cause burning or discomfort in your upper abdomen, along with other symptoms
Glucagon-like peptide-1 (GLP-1) receptor agonistsincluding semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), and liraglutide (Victoza, Saxenda)along with tirzepatide (Mounjaro, Zepbound), a dual GIP/GLP-1 receptor agonist, have transformed the management of type 2 diabetes and obesity
What the Research Shows A 2023 observational study published in eClinicalMedicine examined health outcomes in adults with ADHD who were prescribed GLP-1 medications for weight management